Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / App Notes / 2024 / Applying the 2023 ASCO-CAP guideline updates for HER2 testing in breast cancer

Applying the 2023 ASCO-CAP guideline updates for HER2 testing in breast cancer

01/11/2024

Share

 

The 2023 ASCO-CAP guideline updates for HER2 testing in breast cancer focused on assessment and reporting practices for HER2-low (HER2 IHC 1+, IHC 2+/ISH-) expression. As HER2-low classification can impact decisions made by the clinical care team, it is important to standardize clinical practice to ensure tumors with low levels of HER2 expression are assessed and reported consistently.

Our latest application note discusses how pathology laboratories can implement the 2023 ASCO-CAP guideline update recommendations in practice, with examples from a pathologist who has already started integrating them into their institution.

 

>> Download app note as a PDF

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Explore Agilents open and scalable digital pathology solutions
Explore Agilent’s open and scalable digital pathology solutions

April 2, 2024

Agilent has combined our trusted staining solutions with hand-picked, best-in-class innovations from leaders in industry to offer open, truly end-to-end, scalable, and flexible digital pathology solutions...

Advantages of Using the SLIDEVIEW VS200 Slide Scanner to Adjust Specimen Contrast
Advantages of Using the SLIDEVIEW™ VS200 Slide Scanner to Adjust Specimen Contrast

February 27, 2024

Applying the 2023 ASCO-CAP guideline updates for HER2 testing in breast cancer

January 11, 2024

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.